Oncoinvent ASA
0
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022
Total reported revenue 848K 63K 67K
Cost of revenue 5.1M 10.2M
Gross profit -5.1M -10.2M
Operating expense
Research & development 87.7M 55.2M 17.5M
Selling general and admin 5.7M 13.5M
Other operating expenses 30.1M 6.7M 14.3M
Operating income -151.2M -147.4M -110.6M
Non operating interest income
Income 3.5M 4.4M 4.4M
Expense 0 9K 6K
Other income expense
Pretax income -139.3M -143.6M -106.3M
Tax provision 0
Net income -139.3M -143.6M -106.3M
Basic EPS -2.5 -5.4 -4.0
Diluted EPS -2.5 -5.4 -4.0
Basic average shares 55.0M 26.5M 26.5M
Diluted average shares 55.0M 26.5M 26.5M
EBITDA -138.8M -132.4M -98.3M
Net income from continuing op. -139.3M -143.6M -106.3M
Minority interests
Preferred stock dividends 0 0 0
Access /income_statement data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed (non-working day)
Main market opens in 11 hours 27 minutes

21:32
00:00
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 16:20
All times are displayed in the Europe/Oslo timezone (CET, UTC+01:00).